North Carolina Clinical Research

North Carolina Clinical Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

North Carolina Clinical Research is a well-established, private clinical research organization (CRO) site that has conducted over 650 studies since its founding in 1994. It operates a services-based business model, generating revenue by contracting with pharmaceutical and biotechnology sponsors to conduct Phase I-IV outpatient clinical trials, primarily in respiratory therapeutics. With a core team of approximately 13 professionals boasting over 250 combined years of experience, NCCR has built a strong reputation for patient-centric care and operational reliability in the Raleigh-Durham research hub. Its success is driven by a steady pipeline of sponsor contracts and a dedicated base of repeat volunteer participants.

RespiratoryAsthmaCOPDAllergy

Technology Platform

Operational clinical trial execution platform specializing in outpatient studies, including patient recruitment/retention systems, respiratory-specific diagnostic equipment, and regulatory-compliant data management infrastructure.

Opportunities

The growing global clinical trials market and persistent unmet need in respiratory diseases (asthma, COPD) drive sustained sponsor demand.
Its location in the Research Triangle Park biopharma hub and deep therapeutic specialization position it as a preferred site for relevant studies.
Trends toward decentralized trials favor established outpatient sites with strong local patient management.

Risk Factors

Revenue is entirely dependent on winning sponsor contracts, creating vulnerability to shifts in pharmaceutical R&D spending.
Patient recruitment challenges or failure to meet enrollment targets for key studies could damage sponsor relationships.
Significant regulatory compliance failures could disqualify the site from conducting future trials.

Competitive Landscape

NCCR competes with other independent clinical research sites, large national and global CRO networks, and academic medical centers conducting trials. Its differentiation lies in its deep, niche expertise in respiratory trials, long-standing community presence for patient recruitment, and emphasis on patient-centric care within a smaller, focused operational model.